Status:
NOT_YET_RECRUITING
Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management
Lead Sponsor:
Ankara Ataturk Sanatorium Training and Research Hospital
Conditions:
Epistaxis Nosebleed
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In this randonmized controlled trial, aim to compare the effectiveness of local administration of tranexamic acid and blood stopper (Ankaferd®) on cessation of bleeding in epistaxis patients.
Detailed Description
Anterior tamponade is frequently used in the management of anterior epistaxis. However, this procedure is often uncomfortable for patients. Therefore, instead of this physical tampon, various pharmaco...
Eligibility Criteria
Inclusion
- Patients over 18 years of age with epistaxis will present to the emergency department with non-traumatic epistaxis and whose bleeding do not stop with simple external compression for 10 minutes.
Exclusion
- Patients demonstrating hemodynamic instability
- Patients with documented allergy to tranexamic acid or Ankaferd
- patients with known bleeding disorders,
- patients using anticoagulants,
- pregnant patients
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT06490653
Start Date
October 1 2024
End Date
December 1 2025
Last Update
July 8 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.